Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-178,921
Closed -$13.2M 49
2023
Q4
$13.2M Sell
178,921
-633,579
-78% -$39.2M 0.18% 40
2023
Q3
$37.4M Sell
812,500
-787,500
-49% -$35M 0.58% 22
2023
Q2
$67.5M Sell
1,600,000
-288,888
-15% -$10.9M 0.92% 21
2023
Q1
$49.3M Buy
1,888,888
+333,333
+21% +$9.86M 0.73% 21
2022
Q4
$46.3M Buy
1,555,555
+506,084
+48% +$14.1M 0.69% 22
2022
Q3
$20.4M Hold
1,049,471
0.38% 32
2022
Q2
$14.2M Hold
1,049,471
0.28% 33
2022
Q1
$14.6M Sell
1,049,471
-53,200
-5% -$773K 0.27% 36
2021
Q4
$18.4M Sell
1,102,671
-155,000
-12% -$3.45M 0.31% 33
2021
Q3
$22.3M Buy
+1,257,671
New +$36.5M 0.35% 37

Other funds holding NUVL

Avoro Capital Advisors's NUVL Position: Q1 2024 in Review

Avoro Capital Advisors sold out of Nuvalent (NUVL) in Q1 2024, closing a stake of 178,921 shares — an estimated $13.2M sold.

Avoro Capital Advisors first reported a position in NUVL in Q3 2021 and held it in 10 quarters. The position peaked at $67.5M in Q2 2023. 180 funds tracked by Wall St. Rank hold NUVL as of Q1 2024.

  • Avoro Capital Advisors reported no remaining Nuvalent position as of Q1 2024 after selling out during the quarter.
  • Avoro Capital Advisors sold 178,921 Nuvalent shares in Q1 2024, an estimated $13.2M.
  • Avoro Capital Advisors first reported a position in Nuvalent in Q3 2021 and held it in 10 quarters.
  • Avoro Capital Advisors's Nuvalent position peaked at $67.5M in Q2 2023.
  • 180 funds tracked by Wall St. Rank held Nuvalent as of Q1 2024.

Based on Avoro Capital Advisors's 13F filing for Q1 2024, filed 15 May 2024.